[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-330974-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-330974-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ab-1906-cervical-cancer-screening-technical-brief","AB 1906 Cervical Cancer Screening - Technical Brief","","AB 1906 Cervical Cancer Screening Technical Brief documents the analytical foundation for CHBRP’s assessment of California’s proposed mandate. It explains how legislative text is analyzed and sets out the policy framework, including the state and federal policy landscape, background on cervical cancer, and existing screening effectiveness. The brief details barriers and disparities in access and incorporates cost impact analysis through data sources, caveats, and assumptions, plus guidance on estimating public demand.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ab-1906-cervical-cancer-screening-technical-brief/330974/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ab-1906-cervical-cancer-screening-technical-brief/330974.png","ImageObject",300,407,{"name":42,"@type":43},"Tawan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the AB 1906 Cervical Cancer Screening Technical Brief?","Question",{"text":63,"@type":64},"It provides the analytical foundation for CHBRP’s analysis of AB 1906, supporting a deeper understanding of the topic background and CHBRP’s methodology, research, assumptions, and data sources.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What topics does the brief cover before the cost analysis?",{"text":68,"@type":64},"It reviews the legislative text, policy framework, background on cervical cancer, screening, barriers and disparities in access, and the societal impact in the United States.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the brief conduct the cost impact analysis?",{"text":72,"@type":64},"It presents cost impact analysis using specified data sources, highlights caveats and analytical assumptions, and describes other considerations for policymakers and how public demand for the proposed mandate is determined.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},330974,1791101204,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},2336475104042,"https://ap-avatar.wpscdn.com/avatar/22000c4c32af1715be0?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786537525561427321","AB 1906  \nCervical Cancer Screening  \nTechnical Brief: AB 1906  \nAbout the Technical Brief  \nThis document provides details on the analytical foundation for CHBRP’s analysis of AB 1906. While the main report synthesizes key findings for immediate policy consideration, this document is designed to support a deeper understanding of the background of the topic of the legislation and CHBRP’s methodology and research in conducting its analysis. It contains the data sources, methods, assumptions, and other bill-specific considerations necessary for legislative staff, fiscal analysts, and other stakeholders to fully understand the scope and impact of the proposed measure.  \nCurrent as of April 20, 2026 [i ](i  chbrp.org)[ chbrp.org](i  chbrp.org)  \nTechnical Brief: AB 1906  \nTable of Contents  \nLegislative Text Analyzed .................................................................................................................................................... 1  \nPolicy Framework ................................................................................................................................................................. 3  \nCalifornia and Federal Policy Landscape ............................................................................................................................... 3  \nBackground on Cervical Cancer ......................................................................................................................................... 5  \nCervical Cancer Screening ..................................................................................................................................................... 6  \nBarriers to Accessing Cervical Cancer Screening ..................................................................................................................9  \nDisparities in Cervical Cancer Screening ............................................................................................................................... 9  \nSocietal Impact of Cervical Cancer in the United States ...................................................................................................... 11  \nMedical Effectiveness Review ........................................................................................................................................... 13  \nCost Impact Analysis: Data Sources, Caveats, and Assumptions ................................................................................ 17  \nAnalytical Assumptions ......................................................................................................................................................... 17  \nOther Considerations for Policymakers ................................................................................................................................ 17  \nCost Impact Analysis: Data Sources, Caveats, and Assumptions ........................................................................................ 18  \nDetermining Public Demand for the Proposed Mandate ......................................................................................................21  \nReferences ..........................................................................................................................................................................22  \nCurrent as of April 20, 2026 ii  [chbrp.org](chbrp.org)  \nTechnical Brief: AB 1906  \nLists of Tables and Figures  \nTable 1. Cervical Cancer Incidence Rates per 100,000 in California by Age and R/E, 2018 – 2022 .............................. 5  \nTable 2. Self-Collection HPV Test Kits Approved by the FDA as of April 2026 ...............................................................8  \nTable 3. Adherence to Cervical Cancer Screening Among Californian Women Ages 21–65 Years, by Key Demographic Characteristics, 2016–2020 ..................................................................................................................","cbCaih8qeMiAxKX6","https://ap.wps.com/l/cbCaih8qeMiAxKX6","pdf",833850,34,"English","# Legislative Text Analyzed\n# Policy Framework\n## California and Federal Policy Landscape\n# Background on Cervical Cancer\n# Cervical Cancer Screening\n# Barriers to Accessing Cervical Cancer Screening\n# Disparities in Cervical Cancer Screening\n# Societal Impact of Cervical Cancer in the United States\n# Medical Effectiveness Review\n# Cost Impact Analysis: Data Sources, Caveats, and Assumptions\n## Analytical Assumptions\n## Other Considerations for Policymakers\n# Determining Public Demand for the Proposed Mandate\n# References","[{\"question\":\"What is the purpose of the AB 1906 Cervical Cancer Screening Technical Brief?\",\"answer\":\"It provides the analytical foundation for CHBRP’s analysis of AB 1906, supporting a deeper understanding of the topic background and CHBRP’s methodology, research, assumptions, and data sources.\"},{\"question\":\"What topics does the brief cover before the cost analysis?\",\"answer\":\"It reviews the legislative text, policy framework, background on cervical cancer, screening, barriers and disparities in access, and the societal impact in the United States.\"},{\"question\":\"How does the brief conduct the cost impact analysis?\",\"answer\":\"It presents cost impact analysis using specified data sources, highlights caveats and analytical assumptions, and describes other considerations for policymakers and how public demand for the proposed mandate is determined.\"}]","AB 1906 Cervical Cancer Screening - Technical Brief | PDF",1789990944,86]